Dhampur Bio Organics declares 15% dividend at 6th AGM
Dhampur Bio Organics Limited declared a ₹1.50 per share final dividend for FY26 at its 6th AGM on July 24, 2026. The meeting approved the re-appointment of Gautam Goel as Chairman and CEO, the re-appointment of M/s Mittal Gupta & Co. as statutory auditors for five years, and amendments to the Articles of Association. The audited financial statements for FY26 were adopted without qualification.

*this image is generated using AI for illustrative purposes only.
Dhampur Bio Organics Limited shareholders approved a final dividend of ₹1.50 per equity share (15%) for the financial year ended March 31, 2026, during the company’s 6th Annual General Meeting held on July 24, 2026. The meeting, chaired by Chairman and CEO Gautam Goel, also ratified the adoption of audited standalone and consolidated financial statements, which received no qualifications from the statutory auditors.
The AGM was conducted via Video Conferencing/Other Audio-Visual Means in compliance with Ministry of Corporate Affairs and SEBI circulars. Gautam Goel addressed shareholders, paying homage to the late Vijay Kumar Goel and highlighting the completion of the slump sale of the Meerganj unit. He provided an overview of the sugar industry and the company’s performance in FY26. Nalin Kumar Gupta, Whole-time Director and CFO, presented the financial highlights and segment-wise performance.
Key Resolutions Passed
The following resolutions were passed by the members:
| Resolution Type | Particulars | Status |
|---|---|---|
| Ordinary | Adoption of Audited Standalone and Consolidated Financial Statements for FY26 | Passed |
| Ordinary | Declaration of final dividend @15.00% (₹1.50 per equity share) for FY26 | Passed |
| Ordinary | Re-appointment of Mr. Gautam Goel as Director (retiring by rotation) | Passed |
| Ordinary | Re-appointment of M/s Mittal Gupta & Company as Statutory Auditors for 5 years | Passed |
| Special | Amendment of Articles of Association (inserting new Article 125A) | Passed |
| Special | Re-designation of Mr. Gautam Goel as Chairman and CEO | Passed |
| Special | Amendment in terms of payment of gratuity to Directors | Passed |
| Ordinary | Revision in remuneration of Ms. Maayashree Goel, General Manager | Passed |
| Ordinary | Revision in remuneration of Ms. Meerashree Goel, General Manager | Passed |
| Special | Payment of Commission to Non-Executive Directors for FY26 | Passed |
| Ordinary | Ratification of remuneration to Cost Auditor for FY27 | Passed |
Governance and Attendance
The quorum was present via video conferencing. Bindu Vashist Goel, Non-Executive Director, could not attend due to technical issues, while Ruchika Amrish Mehra Kothari, Independent Director, was absent due to unavoidable circumstances. Chairpersons of the Audit, Stakeholders' Relationship, Nomination and Remuneration, and Risk Management Committees were present.
Statutory Auditor Bihari Lal Gupta of M/s Mittal Gupta & Co., Chartered Accountants, and Secretarial Auditor/Scrutinizer Saket Sharma of M/s GSK & Associates were present via video conferencing. Two registered speakers raised queries, which were addressed by the management team. Remote e-voting was active from July 20, 2026, to July 23, 2026, with additional voting available during the meeting.
Historical Stock Returns for Dhampur Bio Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.68% | -5.76% | -8.51% | +6.61% | +8.78% | -39.27% |
How will the completion of the Meerganj unit slump sale impact Dhampur Bio Organics' debt levels and future capital allocation strategies?
What are the expected implications of the new Article 125A in the Articles of Association on the company's operational flexibility and shareholder rights?
How might the re-designation of Gautam Goel as Chairman and CEO influence the company's long-term strategic direction and corporate governance structure?

































